Advertisement

Topics

Journal Watch (September 2018)

20:33 EDT 15 Sep 2018 | Biotech Due Diligence

Read on for a super-sized collection of scientific and medical journals driving the conversation on Twitter lately:blockbuster review re. targeting BCMA for treatment of multiple #myeloma - via #bispecific #trispecific #ADC #CARTcell and etc etc and #openaccesshttps://t.co/QlCP3maFK0h/t @BiotechRadar— Paul D. Rennert (@PDRennert) September 12, 2018$BMY TYK2 inhibitor psoriasis data out in NEJM: impressive efficacy, safety look quite clean toohttps://t.co/n9RrLCIcV7A few other interesting derm [...]

Original Article: Journal Watch (September 2018)

NEXT ARTICLE

More From BioPortfolio on "Journal Watch (September 2018)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Psoriasis
Psoriasis is a common skin condition affecting 2-3% of the population of the United Kingdom, where the skins replacement process is sped taking 2-6 days instead of the usual 21 - 28 days for the replacement of skin cells. Patients experience an accumulat...